A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
for Atopic Dermatitis (AD)
48 locations incl. Phoenix
Sponsor: Bluefin Biomedicine, Inc.
Sex: All·Age: 18 - 75
Code: NCT07105488·Phase 2·Recruiting·Listed Aug 2025
Skin Cancer and Dermatology Institute
Clinical research site in Sparks, Nevada
Part of Skin Cancer and Dermatology Institute
As of July 2026, 1 paid clinical trial is recruiting at Skin Cancer and Dermatology Institute in Sparks, Nevada. Active studies at this site focus on Atopic Dermatitis (AD) alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .